Lipitor

FDA Begins New Testing of Generic Drug Quality

Posted on 02/26/2014 by | Personal Health and Well-being | Comments

Bulletin Today | Personal HealthFor decades, doctors, drug companies and the Food and Drug Administration have assured us that low-cost prescription generic drugs — which make up an estimated 80 percent of the prescription medicines we take — work just as well as the costlier brand-name drugs they mimic. Except that a growing number of patient complaints, as well as issues over the quality of generics manufactured abroad, have proven that some of them don’t. And it appears the FDA is finally going to …

Does a Top Drugmaker’s Playbook Stifle Competition?

Posted on 06/17/2013 by | News | Comments

Personal HealthIf you owned the bestselling prescription drug of all time and its patent was about to expire, how would you prepare for competition from generic drugs? You might look at what Pfizer did when time was running out on its patent for the cholesterol-lowering drug Lipitor, which by 2011 had become the all-time bestselling prescription drug of any kind. And you could save yourself some time by reviewing a new AARP Public Policy Institute case study of Pfizer’s approach. The …